Polycythemia
Showing 26 - 50 of 447
Polycythemia Vera Trial in Italy
Recruiting
- Polycythemia Vera
-
Reggio Calabria, Calabria, Italy
- +21 more
Nov 10, 2023
Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)
Active, not recruiting
- Myelofibrosis
- Polycythemia Vera
-
Phoenix, Arizona
- +4 more
Jun 20, 2022
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Polycythemia Vera, Essential Thrombocythemia, and
Not yet recruiting
- Myeloproliferative Neoplasm
- Next-generation sequencing
- (no location specified)
Jun 27, 2022
Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)
Active, not recruiting
- Myeloproliferative Neoplasm
- +4 more
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023
Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism Trial in Durham
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperpolarized Xe129
- Oxygen Administration
-
Durham, North CarolinaDuke University Medical Center
Sep 8, 2023
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)
Recruiting
- Primary Myelofibrosis
- +4 more
-
New York, New YorkRuttenberg Treatment Center
Jul 18, 2022
Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles
Not yet recruiting
- Clonal Cytopenia of Undetermined Significance
- +4 more
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +1 more
Oct 4, 2023
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera
Completed
- Adherence, Patient
- Adherence, Treatment
-
Cosenza, Calabria, Italy
- +27 more
Oct 11, 2023
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,
Recruiting
- Primary Myelofibrosis
- +2 more
- NS-018
- Best Available Therapy
-
Worcester, Massachusetts
- +16 more
Oct 31, 2022
Erythrocytosis, Erythropoiesis Abnormal Trial in Copenhagen (Recombinant human erythropoietin)
Completed
- Erythrocytosis
- Erythropoiesis Abnormal
- Recombinant human erythropoietin
-
Copenhagen, DenmarkDepartment of Nutrition, Exercise and Sports
Apr 25, 2023
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Polycythemia Vera (PV) Trial in Japan (P1101 (Ropeginterferon alfa-2b))
Recruiting
- Polycythemia Vera (PV)
- P1101 (Ropeginterferon alfa-2b)
-
Toon-shi, Ehime, Japan
- +5 more
Jun 13, 2022
Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,
Recruiting
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- +3 more
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Late Gestational Diabetes Mellitus Diagnosis in Obese Women
Not yet recruiting
- Gestational Diabetes Mellitus in Pregnancy
- +7 more
- oral glucose tolerance test (OGTT)
-
Nahariyya, IsraelGalil Medical Center
Aug 18, 2022
Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)
Terminated
- Essential Thrombocythemia
- +2 more
- Arsenic Trioxide
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Polycythemia Vera Trial in China (Ropeginterferon alfa-2b)
Active, not recruiting
- Polycythemia Vera
- Ropeginterferon alfa-2b
-
Beijing, China
- +13 more
Aug 1, 2022